The current situation and the future of pediatric blood transfusion

WANG Tian-You; LI Tuo-Zhang

doi:10.7499/j.issn.1008-8830.2405048

PDF(464 KB)

Chinese Journal of Contemporary Pediatrics ›› 2024, Vol. 26 ›› Issue (12) : 1245-1248. DOI: 10.7499/j.issn.1008-8830.2405048

EXPERT COMMENTARY

The current situation and the future of pediatric blood transfusion

WANG Tian-You, LI Tuo-Zhang

Author information +

History +

Abstract

With advancements in clinical medicine, pediatric blood transfusion has evolved from traditional empirical practices to evidence-based approaches grounded in clinical research data. To better guide pediatric blood transfusion practices and improve clinical outcomes for pediatric patients, the National Health Commission has developed and issued "Guideline for pediatric transfusion". This article summarizes the unique aspects of pediatric blood transfusion, the application of blood component therapy in treating pediatric patients, the significance of interpreting the "Guideline for pediatric transfusion", and anticipates future developments in pediatric blood transfusion medicine.

Key words

Pediatric blood transfusion / Blood component / Evidence-based medicine

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

WANG Tian-You, LI Tuo-Zhang. The current situation and the future of pediatric blood transfusion[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(12): 1245-1248 https://doi.org/10.7499/j.issn.1008-8830.2405048

References

1 Josephson CD, Luban NL. Pediatric and neonatal transfusion medicine: a roadmap for research[J]. Transfus Med Rev, 2016, 30(4): 157-158. PMID: 27555063. PMCID: PMC5874793. DOI: 10.1016/j.tmrv.2016.08.003.
2 Cohn CS, Delaney M, Johnson ST, et al. Technical Manual[M]. 20th ed. Bethesda: American Association of Blood Banks, 2020: 771.
3 Wang Y, Sun W, Wang X, et al. Comparison of transfusion reactions in children and adults: a systematic review and meta-analysis[J]. Pediatr Blood Cancer, 2022, 69(9): e29842. PMID: 35758531. DOI: 10.1002/pbc.29842.
4 Sostin N, Hendrickson JE. Pediatric hemovigilance and adverse transfusion reactions[J]. Clin Lab Med, 2021, 41(1): 51-67. PMID: 33494885. DOI: 10.1016/j.cll.2020.10.004.
5 New HV, Grant-Casey J, Lowe D, et al. Red blood cell transfusion practice in children: current status and areas for improvement? A study of the use of red blood cell transfusions in children and infants[J]. Transfusion, 2014, 54(1): 119-127. PMID: 23808415. DOI: 10.1111/trf.12313.
6 Patterson JA, Bowen JR, Francis S, et al. Comparison of neonatal red cell transfusion reporting in neonatal intensive care units with blood product issue data: a validation study[J]. BMC Pediatr, 2018, 18(1): 86. PMID: 29475432. PMCID: PMC5824461. DOI: 10.1186/s12887-018-1005-2.
7 Keir AK, Yang J, Harrison A, et al. Temporal changes in blood product usage in preterm neonates born at less than 30 weeks' gestation in Canada[J]. Transfusion, 2015, 55(6): 1340-1346. PMID: 25652740. DOI: 10.1111/trf.12998.
8 Franz AR, Engel C, Bassler D, et al. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial[J]. JAMA, 2020, 324(6): 560-570. PMID: 32780138. PMCID: PMC7420159. DOI: 10.1001/jama.2020.10690.
9 Case RB, Berglund E, Sarnoff SJ. Ventricular function. VII. Changes in coronary resistance and ventricular function resulting from acutely induced anemia and the effect thereon of coronary stenosis[J]. Am J Med, 1955, 18(3): 397-405. PMID: 14349964. DOI: 10.1016/0002-9343(55)90219-9.
10 Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members[J]. JAMA, 2014, 312(10): 1033-1048. PMID: 25203083. DOI: 10.1001/jama.2014.10517.
11 Josephson CD, Granger S, Assmann SF, et al. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia[J]. Blood, 2012, 120(4): 748-760. PMID: 22538854. PMCID: PMC3462047. DOI: 10.1182/blood-2011-11-389569.
12 Curley A, Stanworth SJ, Willoughby K, et al. Randomized trial of platelet-transfusion thresholds in neonates[J]. N Engl J Med, 2019, 380(3): 242-251. PMID: 30387697. DOI: 10.1056/NEJMoa1807320.
13 Sola-Visner MC. Platelet transfusions in neonates-less is more[J]. N Engl J Med, 2019, 380(3): 287-288. PMID: 30650325. DOI: 10.1056/NEJMe1813419.
14 Mo YD, Delaney M. Transfusion in pediatric patients: review of evidence-based guidelines[J]. Clin Lab Med, 2021, 41(1): 1-14. PMID: 33494878. DOI: 10.1016/j.cll.2020.10.001.
15 Stanworth SJ, Grant-Casey J, Lowe D, et al. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children[J]. Transfusion, 2011, 51(1): 62-70. PMID: 20804532. DOI: 10.1111/j.1537-2995.2010.02798.x.
16 Tinmouth A, Thompson T, Arnold DM, et al. Utilization of frozen plasma in Ontario: a provincewide audit reveals a high rate of inappropriate transfusions[J]. Transfusion, 2013, 53(10): 2222-2229. PMID: 23672421. DOI: 10.1111/trf.12231.
17 Leeper CM, Neal MD, Billiar TR, et al. Overresuscitation with plasma is associated with sustained fibrinolysis shutdown and death in pediatric traumatic brain injury[J]. J Trauma Acute Care Surg, 2018, 85(1): 12-17. PMID: 29443859. DOI: 10.1097/TA.0000000000001836.
18 马婷, 宋奥微, 孙杨, 等. 新生儿输血热点调查[J]. 临床血液学杂志, 2019, 32(8): 632-635. DOI: 10.13201/j.issn.1004-2806-b.2019.08.019.
19 Kirpalani H, Bell EF, Hintz SR, et al. Higher or lower hemoglobin transfusion thresholds for preterm infants[J]. N Engl J Med, 2020, 383(27): 2639-2651. PMID: 33382931. PMCID: PMC8487591. DOI: 10.1056/NEJMoa2020248.
20 Curley A, Stanworth SJ, Willoughby K, et al. Randomized trial of platelet-transfusion thresholds in neonates[J]. N Engl J Med, 2019, 380(3): 242-251. PMID: 30387697. DOI: 10.1056/NEJMoa1807320.
21 Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units[J]. N Engl J Med, 2007, 356(16): 1609-1619. PMID: 17442904. DOI: 10.1056/NEJMoa066240.
22 中华人民共和国国家卫生健康委员会法规司. 关于发布《输血相容性检测标准》等3项推荐性卫生行业标准的通告: 国卫通〔2022〕1号[EB/OL]. (2022-02-23)[2024-05-10]. http://www.nhc.gov.cn/fzs/s7852d/202202/1484f47dcf824ee8bae3ad7b6809e603.shtml.
23 National Institutes of Health. NIH policy and guidelines on the inclusion of children as participants in research involving human subjects[EB/OL]. (1998-03-06)[2024-05-01]. http://grants.nih.gov/grants/guide/notice-files/not98-024.html.
24 Spitalnik SL, Triulzi D, Devine DV, et al. 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium[J]. Transfusion, 2015, 55(9): 2282-2290. PMID: 26260861. PMCID: PMC4573332. DOI: 10.1111/trf.13250.